ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999

CCOPs Payline Set In Low 220s Fr Now; 45 To Be Funded

May 15, 1987

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million

August 19, 1983

ASCO Supports Tobacco Tax Increase

March 7, 2003